Manitoba horse tests positive for equine infectious anemia

CURRENT FULL VERSION: A horse in Minitonas-Bowsman, Manitoba, has tested positive for equine infectious anemia, adding another North American detection in a year when EIA surveillance reports have continued to surface across multiple jurisdictions. The positive result was confirmed on April 30, 2026, by the Canadian Food Inspection Agency’s national reference laboratory, according to the Equine Disease Communication Center alert cited by trade outlets. The horse was sampled to satisfy an export requirement and reportedly had no clinical signs at the time of testing. (equinediseasecc.org)

That detail matters because it fits the long-standing pattern of EIA epidemiology: infected equids are often identified through testing, not illness. CFIA says most EIA-infected horses show no clinical signs, yet remain carriers for life and can infect susceptible animals. In Canada, EIA is a reportable disease under the Health of Animals Act, and the national control program relies on voluntary surveillance testing by industry paired with a mandatory federal response when a positive animal is found. (inspection.canada.ca)

In this Manitoba case, EDCC reporting said movement controls were placed on the infected horse and exposed animals, and that several other equines were present on the premises. Under CFIA’s control program, equines on the affected premises must test negative before they can move off the property, and equines that had contact with the positive animal within 30 days of sampling are also tested. CFIA states that positive equines are ordered destroyed, with compensation potentially available up to a capped amount. (equimanagement.com)

The broader disease-control context is familiar to equine practitioners. Manitoba’s provincial guidance says EIA, sometimes called swamp fever, is spread through blood, including by biting insects and contaminated needles or surgical equipment. More broadly, EDCC-linked case summaries note transmission through exchange of body fluids from infected to uninfected animals, often via blood-feeding insects such as horseflies, as well as blood-contaminated instruments or needles. There is no treatment and no vaccine available in Canada. The standard screening tool remains the Coggins test, which detects antibodies to the virus, and testing is commonly used for shows, sales, movement, pre-event requirements, and export. (gov.mb.ca)

Expert and industry guidance continues to emphasize that surveillance only works when it’s paired with practical biosecurity. AAEP’s EIA guidance identifies the agar gel immunodiffusion test, or Coggins, and ELISA as the main serologic tools, while AAEP biosecurity resources stress that equine practices and facilities should have active plans to prevent disease introduction and spread. AAEP has also highlighted iatrogenic transmission risks, including reuse of needles, syringes, IV equipment, and contamination of multidose vials, as an important concern alongside insect transmission. (aaep.org)

Recent reports from other jurisdictions help show the range of outcomes after an initial positive. In Ontario, for example, a horse in Tay Valley Township reportedly tested positive after sampling requested to meet a pre-event requirement; the horse had no clinical signs, and the horse plus on-premises contacts were placed under official quarantine. In Nevada, two horses at a private Clark County facility initially tested positive, follow-up testing found a third positive horse, and all three were euthanized; the remaining two horses were held under quarantine pending retesting to confirm negative status. In California, a June report described a 16th confirmed EIA case at a Stanislaus County facility, with 11 exposed horses kept under quarantine for another 60 days until their next retest. Together, those reports reinforce that some detections remain single-case investigations while others expand into prolonged, facility-level management events.

The same reports also underscore the clinical and welfare stakes. Although many infected horses never appear ill, those that do can develop progressive loss of body condition, muscle weakness, poor stamina, fever, depression, and anemia. Once infected, a horse remains infected for life and can serve as a reservoir for spread. In some jurisdictions, lifelong strict isolation is theoretically an option, but it requires extreme separation from unaffected equids; in practice, regulatory programs often move toward euthanasia or mandatory destruction of positive animals.

Why it matters: For veterinarians, the Manitoba detection is less about a single horse and more about what it says regarding surveillance value, compliance touchpoints, and client communication. This horse was reportedly tested for export, underscoring how movement-related testing can uncover inapparent carriers before they enter broader networks of transport, competition, sale, or breeding contacts. It’s also a useful moment to reinforce with pet parents that a negative Coggins is not just paperwork; it’s one of the main safeguards supporting equine movement and outbreak prevention in a disease with no vaccine and no curative treatment. (equinediseasecc.org)

For equine practices, the operational implications are straightforward: review blood-borne disease precautions, confirm sample-handling and identification procedures, revisit needle and instrument policies, and remind clients about testing requirements tied to travel, events, sales, and export. Because EIA-positive horses may be clinically normal, case detection depends heavily on testing culture and on veterinarians maintaining credibility around why those tests matter. (inspection.canada.ca)

What to watch: The next developments will likely be additional testing outcomes from the premises and any linked contacts identified by CFIA, which will determine whether this remains an isolated detection or expands into a larger exposure investigation. Given the recent stream of EDCC EIA alerts from other regions, practitioners should also expect continued attention on surveillance compliance, movement documentation, quarantine follow-up, and biosecurity messaging through the 2026 equine travel season. (inspection.canada.ca)